Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Severe outcomes in unvaccinated COVID-19 cases <18 years during different variant waves in Norway

Robert Whittaker, Margrethe Greve-Isdahl, Håkon Bøås, Pål Suren, Eirik Alnes Buanes, Lamprini Veneti
doi: https://doi.org/10.1101/2022.03.29.22273093
Robert Whittaker
aDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
(MSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Robert.Whittaker@fhi.no
Margrethe Greve-Isdahl
aDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
(MD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Håkon Bøås
bDepartment of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pål Suren
cDepartment of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway
(MD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eirik Alnes Buanes
dDepartment of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway
eNorwegian Intensive Care and Pandemic Registry, Haukeland University Hospital, Bergen, Norway
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lamprini Veneti
bDepartment of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway
(MSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives We used linked individual-level data from national registries to compare the risk of severe outcomes among unvaccinated COVID-19 cases <18 years between waves of the SARS-CoV-2 Alpha, Delta and Omicron variants in Norway.

Methods Our outcomes were hospitalisation with acute COVID-19 or multisystem inflammatory syndrome in children (MIS-C). We calculated adjusted risk ratios (aRR) with 95% confidence intervals (CIs) using multivariable log-binomial regression, adjusting for variant wave, demographic characteristics and underlying comorbidities.

Results We included 10,538 Alpha (21 hospitalised with acute COVID-19, 7 MIS-C), 42,362 Delta (28 acute COVID-19, 14 MIS-C) and 82,907 Omicron wave cases (48 acute COVID-19, 7 MIS-C). The risk of hospitalisation with acute COVID-19 in cases <1 year was lower in the Delta (aRR: 0.28, 95% CI: 0.16–0.89) and Omicron wave (aRR: 0.41, 95% CI: 0.20–0.81), compared to the Alpha wave. We found no difference in the risk for this outcome for Omicron compared to Delta in any age group. The risk of MIS-C was lower in the Omicron wave compared to the Alpha (aRR: 0.09, 95% CI: 0.03–0.27) and Delta wave (aRR: 0.26, 95% CI: 0.10–0.63).

Conclusions We found no evidence of a difference in the risk of hospitalisation due to acute COVID-19 among unvaccinated cases <18 years for Omicron compared to Delta, but a reduced risk among cases <1 year in Omicron and Delta waves, compared to Alpha. Results also suggest a decrease in the risk of MIS-C in the Omicron wave compared to the Alpha and Delta waves.

Article Summary We compare the risk of severe outcomes in unvaccinated COVID-19 cases <18 years between waves of the SARS-CoV-2 Alpha, Delta and Omicron variant in Norway.

What’s Known on This Subject Currently, limited evidence suggests no clear difference in the risk of severe disease outcomes among children infected with different SARS-CoV-2 variants. The risk of multisystem inflammatory syndrome in children following infection with the Omicron variant has not been quantified.

What This Study Adds We find a lower risk of hospitalisation due to acute COVID-19 among cases <1 year in the Delta and Omicron waves compared to the Alpha wave, and a lower risk of multisystem inflammatory syndrome in the Omicron wave, in Norway.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was undertaken as part of routine work at the Norwegian Institute of Public Health. No specific funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval for studies on the risk of severe disease by SARS-CoV-2 variant based on data from the national preparedness registry for COVID-19 was granted by Regional Committees for Medical Research Ethics - South East Norway, reference number 249509.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of interest: The authors declare that they have no competing interests.

  • Funding: This research was undertaken as part of routine work at the Norwegian Institute of Public Health. No specific funding was received.

Data Availability

The dataset analyzed in the study contains individual-level linked data from various central health registries, national clinical registries, and other national administrative registries in Norway. The researchers had access to the data through the national emergency preparedness registry for COVID-19 (Beredt C19), housed at the Norwegian Institute of Public Health (NIPH). In Beredt C19, only fully anonymized data (i.e. data that are neither directly nor potentially indirectly identifiable) are permitted to be shared publicly. Legal restrictions therefore prevent the researchers from publicly sharing the dataset used in the study that would enable others to replicate the study findings. However, external researchers are freely able to request access to linked data from the same registries from outside the structure of Beredt C19, as per normal procedure for conducting health research on registry data in Norway. Further information on Beredt C19, including contact information for the Beredt C19 project manager and information on access to data from each individual data source, is available at https://www.fhi.no/en/id/infectious-diseases/coronavirus/emergency-preparedness-register-for-covid-19/.

  • Abbreviations

    VOC
    Variant of concern
    SARS-CoV-2
    Severe acute respiratory syndrome coronavirus 2
    COVID-19
    Coronavirus disease
    MIS-C
    Multisystem inflammatory syndrome in children
    LoS
    Length of stay
    ICU
    intensive care unit
    aRR
    Adjusted risk ratio
    CI
    Confidence interval
    PCR
    Polymerase chain reaction
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted March 30, 2022.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Severe outcomes in unvaccinated COVID-19 cases
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Severe outcomes in unvaccinated COVID-19 cases <18 years during different variant waves in Norway
    Robert Whittaker, Margrethe Greve-Isdahl, Håkon Bøås, Pål Suren, Eirik Alnes Buanes, Lamprini Veneti
    medRxiv 2022.03.29.22273093; doi: https://doi.org/10.1101/2022.03.29.22273093
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Severe outcomes in unvaccinated COVID-19 cases <18 years during different variant waves in Norway
    Robert Whittaker, Margrethe Greve-Isdahl, Håkon Bøås, Pål Suren, Eirik Alnes Buanes, Lamprini Veneti
    medRxiv 2022.03.29.22273093; doi: https://doi.org/10.1101/2022.03.29.22273093

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Pediatrics
    Subject Areas
    All Articles
    • Addiction Medicine (269)
    • Allergy and Immunology (552)
    • Anesthesia (135)
    • Cardiovascular Medicine (1752)
    • Dentistry and Oral Medicine (238)
    • Dermatology (172)
    • Emergency Medicine (312)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (657)
    • Epidemiology (10792)
    • Forensic Medicine (8)
    • Gastroenterology (586)
    • Genetic and Genomic Medicine (2939)
    • Geriatric Medicine (287)
    • Health Economics (532)
    • Health Informatics (1921)
    • Health Policy (835)
    • Health Systems and Quality Improvement (744)
    • Hematology (291)
    • HIV/AIDS (628)
    • Infectious Diseases (except HIV/AIDS) (12510)
    • Intensive Care and Critical Care Medicine (687)
    • Medical Education (299)
    • Medical Ethics (86)
    • Nephrology (324)
    • Neurology (2791)
    • Nursing (151)
    • Nutrition (432)
    • Obstetrics and Gynecology (557)
    • Occupational and Environmental Health (597)
    • Oncology (1460)
    • Ophthalmology (443)
    • Orthopedics (172)
    • Otolaryngology (255)
    • Pain Medicine (190)
    • Palliative Medicine (56)
    • Pathology (380)
    • Pediatrics (865)
    • Pharmacology and Therapeutics (363)
    • Primary Care Research (336)
    • Psychiatry and Clinical Psychology (2636)
    • Public and Global Health (5350)
    • Radiology and Imaging (1009)
    • Rehabilitation Medicine and Physical Therapy (595)
    • Respiratory Medicine (726)
    • Rheumatology (329)
    • Sexual and Reproductive Health (289)
    • Sports Medicine (278)
    • Surgery (327)
    • Toxicology (47)
    • Transplantation (149)
    • Urology (125)